Total Tumor Volume on (18)F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with (225)Ac-PSMA-I&T
在接受 PSMA 靶向 α 疗法(使用 (225)Ac-PSMA-I&T)的转移性去势抵抗性前列腺癌 (mCRPC) 患者中,(18)F-PSMA-1007 PET 上的总肿瘤体积可作为额外的影像学生物标志物。
期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines10050946
Unterrainer, Lena M; Beyer, Leonie; Zacherl, Mathias J; Gildehaus, Franz J; Todica, Andrei; Kunte, Sophie C; Holzgreve, Adrien; Sheikh, Gabriel T; Herlemann, Annika; Casuscelli, Jozefina; Brendel, Matthias; Albert, Nathalie L; Wenter, Vera; Schmidt-Hegemann, Nina-Sophie; Kunz, Wolfgang G; Cyran, Clemens C; Ricke, Jens; Stief, Christian G; Bartenstein, Peter; Ilhan, Harun; Unterrainer, Marcus